MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,427,331 | +6.2% | 16,621 | +68.0% | 0.00% | 0.0% |
| Q2 2023 | $2,285,052 | -29.4% | 9,892 | -26.0% | 0.00% | -40.0% |
| Q1 2023 | $3,238,774 | -76.2% | 13,369 | -71.4% | 0.01% | -76.2% |
| Q4 2022 | $13,584,861 | -99.0% | 46,804 | +116.6% | 0.02% | +950.0% |
| Q3 2022 | $1,404,044,000 | +611.7% | 21,604 | +683.9% | 0.00% | – |
| Q2 2022 | $197,274,000 | +102.7% | 2,756 | +177.8% | 0.00% | – |
| Q1 2022 | $97,335,000 | -53.7% | 992 | -60.0% | 0.00% | – |
| Q4 2021 | $210,409,000 | +27.9% | 2,483 | +20.5% | 0.00% | – |
| Q3 2021 | $164,447,000 | +295.4% | 2,061 | +382.7% | 0.00% | – |
| Q2 2021 | $41,594,000 | -66.5% | 427 | -59.8% | 0.00% | – |
| Q1 2021 | $124,222,000 | +17.1% | 1,062 | +11.3% | 0.00% | – |
| Q4 2020 | $106,056,000 | -56.5% | 954 | -53.6% | 0.00% | – |
| Q3 2020 | $243,871,000 | +33.5% | 2,054 | +27.3% | 0.00% | – |
| Q2 2020 | $182,672,000 | -52.3% | 1,613 | -71.9% | 0.00% | -100.0% |
| Q1 2020 | $382,869,000 | +275.2% | 5,735 | +412.1% | 0.00% | – |
| Q4 2019 | $102,043,000 | -12.0% | 1,120 | -16.7% | 0.00% | – |
| Q3 2019 | $115,966,000 | +13.5% | 1,345 | +37.9% | 0.00% | – |
| Q2 2019 | $102,190,000 | -48.9% | 975 | -38.9% | 0.00% | – |
| Q1 2019 | $199,790,000 | +1937.2% | 1,595 | +1733.3% | 0.00% | – |
| Q4 2018 | $9,807,000 | -83.8% | 87 | -69.1% | 0.00% | – |
| Q3 2018 | $60,385,000 | +13.6% | 282 | +48.4% | 0.00% | – |
| Q2 2018 | $53,141,000 | -54.4% | 190 | -80.9% | 0.00% | – |
| Q1 2018 | $116,440,000 | +48.2% | 997 | +16.5% | 0.00% | – |
| Q4 2017 | $78,572,000 | +342.2% | 856 | +116.7% | 0.00% | – |
| Q3 2017 | $17,767,000 | +157.7% | 395 | -6.8% | 0.00% | – |
| Q2 2017 | $6,894,000 | – | 424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |